A stepwise process of mutation and structural analysis has modulated a flexible binding interface of an immune-cell signalling protein, interleukin-2, and generated mutant proteins with enhanced anticancer activity. See Article p.529
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Levin, A. M. et al. Nature 484, 529–533 (2012).
Malek, T. R. & Castro, I. Immunity 33, 153–165 (2010).
Wang, X., Rickert, M. & Garcia, K. C. Science 310, 1159–1163 (2005).
Arima, N. et al. J. Exp. Med. 176, 1265–1272 (1992).
Eklund, J. W. & Kuzel, T. M. Curr. Opin. Oncol. 16, 542–546 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boder, E. Tighter ties that bind. Nature 484, 463–464 (2012). https://doi.org/10.1038/484463a
Published:
Issue Date:
DOI: https://doi.org/10.1038/484463a